Mineralys Therapeutics Inc. (MLYS) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Mineralys Therapeutics In...

    NASDAQ: MLYS · Real-Time Price · USD
    38.06
    -2.40 (-5.93%)
    At close: Oct 03, 2025, 3:59 PM
    38.50
    1.16%
    After-hours: Oct 03, 2025, 07:30 PM EDT

    Mineralys Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -3.36 -4.33 -3.2 -4.74
    PEG Ratio
    		 -0.04 0.07 -0.07 -0.01
    PS Ratio
    		 n/a n/a n/a n/a
    PB Ratio
    		 3.12 1.29 -1.82 -4.01
    P/FCF Ratio
    		 -3.59 -3.83 -3.26 -6.31
    P/OCF Ratio
    		 -3.59 -3.83 -3.26 -6.31
    OCF/S Ratio
    		 n/a n/a n/a n/a
    Debt / Equity Ratio
    		 n/a n/a n/a n/a
    Quick Ratio
    		 14.02 23.76 13.98 2.20
    Current Ratio
    		 14.02 23.76 13.98 2.20
    Asset Turnover
    		 n/a n/a n/a n/a
    Interest Coverage
    		 n/a n/a -18.78 -693.52
    Return on Equity
    		 -0.93 -0.3 0.57 0.85
    Return on Assets
    		 -0.86 -0.29 -0.26 -1.74
    Return on Invested Capital
    		 -1.01 -0.35 -0.29 -3.08
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a n/a

    Add to Watchlist